SACUBITRIL VALSARTAN

DRUG2 trials

Sponsors

Fakultni Nemocnice Ostrava, Policlinico San Donato S.p.A.

Conditions

Chronic heart failure with reduced ejection fractionHeart Failure

Phase 4

Use of determination of drug levels to optimize pharmacotherapy of heart failure

RecruitingCTIS2023-506283-13-00

Fakultni Nemocnice OstravaChronic heart failure with reduced ejection fraction

Start: 2024-04-09Target: 100Updated: 2024-03-12

Pharmacological optimization in prevention in Heart Failure: A Sex-gap? (PopS-HF Trial)

Not yet recruitingCTIS2025-520660-18-00

Policlinico San Donato S.p.A.Heart Failure

Target: 368Updated: 2025-11-17